Cape Investment Advisory, Inc.

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1944437 MCDONOUGH, GA

Position in ALNY

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$8,127

-$7,380 QoQ

Shares Held

-30.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#691

of 784 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cape Investment Advisory, Inc. holds $406,155 across 34 Biotechnology names. ALNY ranks #7 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	2,430	$94,794
2	VRTX	Vertex Pharmaceuticals Inc / Ma	181	$89,907
3	SNDX	Syndax Pharmaceuticals Inc	3,709	$81,078
4	MDXG	Mimedx Group, Inc.	5,500	$21,175
5	EXEL	Exelixis, Inc.	313	$17,030
6	ARGX	Argenx SE	12	$11,132
7	ALNY	Alnylam Pharmaceuticals, Inc. This page	27	$8,127
8	INSM	INSMED Inc	69	$7,356

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,127	27	-30.8%	Shares	Sole	2026-07-23
2025-12-31	$15,507	39	-63.9%	Shares	Sole	2026-02-17
2025-09-30	$49,248	108	+8.0%	Shares	Sole	2025-12-29
2025-06-30	$32,609	100	+11.1%	Shares	Defined	2025-08-19
2025-03-31	$24,301	90	0.0%	Shares	Sole	2025-05-16
2024-12-31	$21,177	90	0.0%	Shares	Sole	2025-02-05
2024-09-30	$24,752	90	0.0%	Shares	Sole	2024-11-14
2024-06-30	$21,870	90	0.0%	Shares	Sole	2024-08-15
2024-03-31	$13,450	90	0.0%	Shares	Defined	2024-06-21
2023-12-31	$17,226	90	-3.2%	Shares	Sole	2024-02-12
2023-09-30	$16,470	93	0.0%	Shares	Defined	2023-11-07
2023-06-30	$17,664	93	-3.1%	Shares	Sole	2023-10-12
2023-03-31	$19,230	96	—	Shares	Sole	2023-10-12
No filing history on record for this holder in this stock.